A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): a case report and literature review

Cancer Genetics and Cytogenetics

Volumn 176, Issue 1, 2007, Pages 72-75

  van Binsbergen, Ellen ^a   de Weerdt, Okke ^b   Buijs, Arjan ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GENE PRODUCT; IDARUBICIN; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MITOXANTRONE; MLL SEPT2 PROTEIN; PREDNISONE; PROCARBAZINE; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER THERAPY; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME 2Q; DISEASE SEVERITY; GENETIC TRANSCRIPTION; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

AGED; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 2; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PHOSPHORIC MONOESTER HYDROLASES; TRANSLOCATION, GENETIC;

EID: 34250167598     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.04.001     Document Type: Article

References (9)

1. Daser A., and Rabbitts T.H. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis. Semin Cancer Biol 15 (2005) 175-188
2. Bhatia S., and Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2 (2002) 124-132
3. Meyer C., Schneider B., Jakob S., Strehl S., Attarbaschi A., Schnittger S., Schoch C., Jansen M.W.J.C., van Dongen J.J.M., den Boer M.L., Pieters R., Ennas M.-G., Angelucci E., Koehl U., Greil J., Griesinger F., zur Stadt U., Eckert C., Szczepaski T., Niggli F.K., Schäfer B.W., Kempski H., Brady H.J.M., Zuna J., Trka J., Nigro L.L., Biondi A., Delabesse E., Macintyre E., Stanulla M., Schrappe M., Haas O.A., Burmeister T., Dingermann T., Klingebiel T., and Marschalek R. The MLL recombinome of acute leukemias. Leukemia 20 (2006) 777-784
4. Cerveira N., Correia C., Bizarro S., Pinto C., Lisboa S., Mariz J.M., Marques M., and Teixeira M.R. SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23). Oncogene 25 (2006) 6147-6152
5. Gabert J., Beillard E., van der Velden V.H., Bi W., Grimwade D., Pallisgaard N., Barbany G., Cazzaniga G., Cayuela J.M., Cavé H., Pane F., Aerts J.L.E., De Micheli D., Thirion X., Pradel V., González M., Viehmann S., Malec M., Saglio G., and van Dongen J.J.M. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 17 (2003) 2318-2357
6. Russell S.E., and Hall P.A. Do septins have a role in cancer?. Br J Cancer 93 (2005) 499-503
7. DeLozier-Blanchet C.D., Cabrol C., Werner-Favre C., Beris P., and Engel E. Translocation 2;11 and other significant chromosome changes in acute monoblastic leukemia (M5) with clonal evolution: sequential clinical and cytogenetic studies. Cancer Genet Cytogenet 16 (1985) 95-102
8. Winick N.J., McKenna R.W., Shuster J.J., Schneider N.R., Borowitz M.J., Bowman W.P., Jacaruso D.J., Kamen B.A., and Buchanan G.R. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide. J Clin Oncol 11 (1993) 209-217
9. Fischer K., Frohling S., Scherer S.W., McAllister Brown J., Scholl C., Stilgenbauer S., Sui L.-C., Lichter P., and Dohner H. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 89 (1997) 2036-2041